Eli Lilly (LLY) Builds In Richmond As Fair Value Still Sits Higher

Eli Lilly (LLY) just put a shovel in the ground on a new US$5b manufacturing hub near Richmond, Virginia, a fully integrated site for active ingredients and finished antibody drug conjugate medicines. Eli Lilly shares have been on a strong run, with a 30 day share price return of 11.67% and a year to date share price gain of 20.95%. The 1 year total shareholder return of 60.15% and 5 year total shareholder return of 439.71% point to powerful longer term momentum that recent drug data,...